Inozyme Pharma
INZY
#8147
Rank
S$0.26 B
Marketcap
$4.05
Share price
6.41%
Change (1 day)
-30.82%
Change (1 year)

Earnings for Inozyme Pharma (INZY)

Earnings in 2024 (TTM): -S$0.12 Billion

According to Inozyme Pharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$84.79 Million, an increase over its 2022 earnings that were of -S$93.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inozyme Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.12 Billion34.4%
2023 -S$84.79 Million-8.89%
2022 -S$93.06 Million21.24%
2021 -S$76.76 Million-0.69%
2020 -S$77.3 Million174.17%
2019 -S$28.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.19 Billion 57.03%๐Ÿ‡บ๐Ÿ‡ธ USA